Dittrich C - Search Results

1

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. Among authors: dittrich c. J Clin Oncol. 2001 Sep 1;19(17):3740-4. doi: 10.1200/JCO.2001.19.17.3740. J Clin Oncol. 2001. PMID: 11533096 Clinical Trial.

2

2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, Lang A, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. Among authors: dittrich c. J Clin Oncol. 2004 Mar 15;22(6):1034-9. doi: 10.1200/JCO.2004.07.188. J Clin Oncol. 2004. PMID: 15020605

3

FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.

Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, Pont J, Dudczak R, Dittrich C, Kletter K. Becherer A, et al. Among authors: dittrich c. Eur J Radiol. 2005 May;54(2):284-8. doi: 10.1016/j.ejrad.2004.07.012. Eur J Radiol. 2005. PMID: 15837411 Clinical Trial.

4

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

Bachner M, Loriot Y, Gross-Goupil M, Zucali PA, Horwich A, Germa-Lluch JR, Kollmannsberger C, Stoiber F, Fléchon A, Oechsle K, Gillessen S, Oldenburg J, Cohn-Cedermark G, Daugaard G, Morelli F, Sella A, Harland S, Kerst M, Gampe J, Dittrich C, Fizazi K, De Santis M. Bachner M, et al. Among authors: dittrich c. Ann Oncol. 2012 Jan;23(1):59-64. doi: 10.1093/annonc/mdr052. Epub 2011 Apr 2. Ann Oncol. 2012. PMID: 21460378 Free article.

5

Effective salvage therapy with carboplatin/mitomycin C in metastatic breast cancer.

Baur M, Kienzer H, DeSantis M, Postner G, Pont J, Hudec M, Dittrich C. Baur M, et al. Among authors: dittrich c. Onkologie. 2002 Jun;25(3):249-54. doi: 10.1159/000064318. Onkologie. 2002. PMID: 12119459 Clinical Trial.

6

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial.

Baur M, Kienzer HR, Schweiger J, DeSantis M, Gerber E, Pont J, Hudec M, Schratter-Sehn AU, Wicke W, Dittrich C. Baur M, et al. Among authors: dittrich c. Cancer. 2002 Jun 1;94(11):2953-8. doi: 10.1002/cncr.10574. Cancer. 2002. PMID: 12115384 Free article. Clinical Trial.

7

Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.

De Santis M, Bachner M, Cerveny M, Kametriser G, Steininger T, Königsberg R, Schratter-Sehn A, Sedlmayer F, Dittrich C. De Santis M, et al. Among authors: dittrich c. Ann Oncol. 2014 Sep;25(9):1789-1794. doi: 10.1093/annonc/mdu209. Epub 2014 Jun 16. Ann Oncol. 2014. PMID: 24936582 Free article. Clinical Trial.

8

Cell cycle dysregulation influences survival in high risk breast cancer patients.

Königsberg R, Rögelsperger O, Jäger W, Thalhammer T, Klimpfinger M, De Santis M, Hudec M, Dittrich C. Königsberg R, et al. Among authors: dittrich c. Cancer Invest. 2008 Aug;26(7):734-40. doi: 10.1080/07357900801944864. Cancer Invest. 2008. PMID: 18665474

9

A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.

Dittrich C, Petruzelka L, Vodvarka P, Gneist M, Janku F, Kysela T, Melemed A, Latz J, Simms L, Krejcy K. Dittrich C, et al. Clin Cancer Res. 2006 Dec 1;12(23):7071-8. doi: 10.1158/1078-0432.CCR-05-2829. Clin Cancer Res. 2006. PMID: 17145830 Clinical Trial.

10

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.

Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C. Königsberg R, et al. Among authors: dittrich c. Acta Oncol. 2011 Jun;50(5):700-10. doi: 10.3109/0284186X.2010.549151. Epub 2011 Jan 24. Acta Oncol. 2011. PMID: 21261508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page